Message from Our CEO

Taiyo Kuroda, MD, PhD

Innovating the Rhythm of Life

My dream began when I was five years old. I envisioned a future where no one would have to die from heart failure—a world where mechanical hearts could seamlessly sustain life. This vision guided me to become a cardiac surgeon, transforming my childhood dream into a profound mission.

Working closely with patients, I witnessed both the miracle of modern medical technology and its limitations. In 2021, joining the artificial heart development team at Cleveland Clinic marked a pivotal moment in transforming this understanding into tangible innovation.

Our mission extends far beyond developing another artificial heart. Current artificial hearts still require external power lines. This challenge represents an opportunity to pioneer a new frontier in internal medical devices.

If we succeed in generating enough internal power to drive an artificial heart, we won't just solve a medical challenge—we'll unlock a new form of bioenergy for humanity, catalyzing innovations as revolutionary as the transistor.

Our journey begins with delivering the ideal artificial heart to patients who suffer daily, leading to a new era in in-body electronics.

Taiyo Kuroda, MD, PhD

Our Team

Taiyo Kuroda

Taiyo Kuroda

CEO & Founder

MD, PhD

Cardiovascular Surgery, Mechanical Circulatory Support Development

Kensuke Takagi

Kensuke Takagi

Medical Technology Lead

MD, PhD

Cardiology, Heart Failure, Intervention (Ischemic, Structure Valve)

Takuro Imaoka

Takuro Imaoka

MD

Cardiology, Heart Failure, Cardio-oncology

Shin Kawazoe

Shin Kawazoe

Commercial Lead

MBA

Marketing, Corporate Strategy, IP

Yuki Kuramochi

Yuki Kuramochi

Regulatory Affair

BSN, RN

Clinical Research, FDA Regulatory Affairs, Medical Device Development

© 2026 Helioverse Innovations. All rights reserved.